Halia Therapeutics to Participate in the Morgan Stanley 23rd Annual Global Healthcare Conference
LEHI, Utah, Sept. 4, 2025 /PRNewswire/ -- Halia Therapeutics, Inc., a clinical-stage…
JUST ON SLEEP Officially Launches on Shopee Singapore, Redefining Sleep Safety and Wellness
SINGAPORE, Sept. 03, 2025 (GLOBE NEWSWIRE) -- JUST ON SLEEP, a smart…
Mesoblast Enters Into Option To Issue US$50 Million Convertible Notes
September 03, 2025 21:47 ET | Source: Mesoblast Limited NEW YORK, Sept.…
BioSig Technologies Supplements Clarification on Recent Schedule 14A Filing. Closing of Merger with Streamex Exchange Corporation Not Affected
Proposal No. 1 (The Acquisition Proposal) to be adjourned pending final NASDAQ…
Mineralys Therapeutics Announces Pricing of Upsized $250.0 Million Underwritten Public Offering of Common Stock
September 02, 2025 21:33 ET | Source: Mineralys Therapeutics, Inc. RADNOR, Pa.,…
Seegene and Springer Nature Open Applications for 2025-2026 Nature Awards MDx Impact Grants
- The program focuses on antibiotic resistance in urinary tract infections (UTI-DR),…
ZEISS showcases expansion of ophthalmic care options creating industry-leading workflow solutions; marks new refractive and cataract milestones
ZEISS Medical Technology will showcase new ophthalmic innovations and market milestones at…
Pharming Group appoints Kenneth Lynard as Chief Financial Officer
Leiden, the Netherlands, September 2, 2025: Pharming Group N.V. (“Pharming” or “the Company”)…
Upstream Bio to Host Conference Call and Webcast to Report Top-Line Data from the Phase 2 VIBRANT Trial of Verekitug in Patients with Chronic Rhinosinusitis with Nasal Polyps (CRSwNP)
WALTHAM, Mass., Sept. 01, 2025 (GLOBE NEWSWIRE) -- Upstream Bio, Inc. (Nasdaq:…
Norma Completes Quantum AI Algorithm Validation on NVIDIA
"Quantum AI up to 73x Faster on NVIDIA CUDA-Q" Norma, a quantum…